---
title: "UBOX ONLINE plans to issue up to 157.5 million placement shares at a discount of approximately 16.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258232222.md"
description: "UBOX ONLINE announced plans to place up to 157.5 million shares at a price of HKD 2.45 per share, representing a discount of approximately 16.95%. The shares being placed account for about 19.96% of the issued H shares and approximately 18.94% of the total issued shares. The total amount expected to be raised from the placement is approximately HKD 386 million, with a net amount of about HKD 383 million, primarily for the development of products, expansion of sales channels, acquisition of fixed assets, and working capital. The board of directors believes that this move will enhance liquidity and financial condition, optimize capital structure, and support sustainable development"
datetime: "2025-09-21T10:36:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258232222.md)
  - [en](https://longbridge.com/en/news/258232222.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258232222.md)
---

# UBOX ONLINE plans to issue up to 157.5 million placement shares at a discount of approximately 16.95%

According to the announcement from UBOX ONLINE (02429), on September 19, 2025, the company entered into a placement agreement with the placing agent. The company agreed to appoint the placing agent, and the placing agent agreed to act as the company's agent to use its best efforts to procure not less than six placees (who will be institutional professional investors, and their ultimate beneficial owners will be independent third parties) to subscribe for up to 157.5 million placement shares at a placement price of HKD 2.45 per share.

The 157.5 million placement shares represent approximately 19.96% of the issued H shares as of the date of this announcement and approximately 18.94% of the total issued shares, and approximately 16.64% of the issued H shares and approximately 15.93% of the total issued shares after the placement shares are allotted and issued (assuming that the number of issued shares of the company remains unchanged from the date of this announcement until the completion of the placement). The placement price of HKD 2.45 per placement share represents a discount of approximately 16.95% to the closing price of HKD 2.95 per H share reported on the Stock Exchange on September 19, 2025.

Assuming all placement shares are fully placed and completed, the total proceeds from the placement are expected to be approximately HKD 386 million, and the net proceeds from the placement are expected to be approximately HKD 383 million. On this basis, the net placement price will be approximately HKD 2.43 per placement share. Approximately 20.0% of the net proceeds from the placement will be used for the development of proprietary intellectual property-based products; approximately 20.0% of the net proceeds from the placement will be used to support the expansion of offline sales channels for proprietary intellectual property-based products; approximately 30.0% of the net proceeds from the placement will be used for the acquisition of fixed assets, including but not limited to vending machines to be added for the expected sales of proprietary intellectual property-based products; and approximately 30.0% of the net proceeds from the placement will be used for working capital and other general corporate purposes.

The directors believe that the placement will enhance the group's liquidity and financial position, expand the company's shareholder base, optimize the company's capital structure, and support the company's healthy and sustainable development

### Related Stocks

- [02429.HK](https://longbridge.com/en/quote/02429.HK.md)

## Related News & Research

- [Shanghai Xizhi switches non-registered investors to online disclosures by default](https://longbridge.com/en/news/287205161.md)
- [Advance Metals Moves Towards Full Ownership of Myrtleford and Beaufort Gold Projects](https://longbridge.com/en/news/287147459.md)
- [Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS](https://longbridge.com/en/news/287235165.md)
- [Alibaba Files Form 13F as Investment Manager, Highlights WVR Structure](https://longbridge.com/en/news/286686984.md)
- [Wendel publishes presentation for May 21, 2026 annual shareholder meeting](https://longbridge.com/en/news/287222898.md)